Rigid Endoscopes Market size was valued at USD 8.02 billion in 2024 and is likely to cross USD 19.09 billion by 2037, registering more than 6.9% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of rigid endoscopes is estimated at USD 8.93 billion.
The market is growing mainly due to the increasing preference for minimally invasive surgical (MIS) procedures to minimize patient trauma. Every year, over 13 million laparoscopic procedures are performed worldwide. These figures are expected to rise by 1% over the next five years.
The growing demand for early diagnosis through minimally invasive procedures drives the use of rigid endoscopes in the healthcare industry, which includes shorter hospital stays, less pain, and fewer complications among patients. This, in turn, improves patient outcomes and treatment efficiency, thereby aiding market growth.
Growth Drivers
Challenges
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
6.9% |
|
Base Year Market Size (2024) |
USD 8.02 billion |
|
Forecast Year Market Size (2037) |
USD 19.09 billion |
|
Regional Scope |
|
Product (Laparoscopes, Arthroscopes, Ureteroscopes, Cystoscopes, Gynecology Endoscopes, Neuroendoscopes, Bronchoscopes, Hysteroscopes)
The product segment is estimated to hold around 29% share of the global rigid endoscopes market by the end of 2037 as a result of the increasing rate of surgeries conducted such as hernias, appendicitis, hysterectomy, endometriosis, cholecystitis, and others. Almost 10% of the population in the United States develops some type of hernia during life and more than 1 million abdominal hernia laparoscopic repairs are performed each year.
End-Use (Hospitals, Outpatient Facilities)
The hospitals sub-segment is expected to gain a prominent share of the rigid endoscopes market by 2037 because hospitals employ skilled surgeons, and most patients choose to have endoscope-related surgeries there. Endoscopic surgery patients make up a sizable portion of hospital patients, which is anticipated to support the segment growth.
Our in-depth analysis of the global market includes the following segments:
|
Product |
|
|
End-Use |
|
North American Market Forecast
North America industry is predicted to dominate majority revenue share of 38% by 2037, as a result of the increasing awareness about endoscopic surgeries for the diagnosis and treatment of various acute and chronic diseases. In the coming years, the region is also expected to present lucrative growth opportunities for market expansion due to rising cancer tumor prevalence, strong healthcare infrastructure, and the availability of prominent key players. According to the American Cancer Society, more than 1.8 million new cases of cancer were identified in the U.S. in 2021.
APAC Market Analysis
The rigid endoscopes market in Asia Pacific will register a revenue share of more than 28% by the end of 2037. The market is expanding as a result of the region's growing preference for elective endoscopic surgeries, increased healthcare spending, and a rapidly growing geriatric population. According to the World Health Organization, the proportion of people aged 60 years and above in the South East Asia region was 9.5% in 2017, and it is expected to rise to 13.2% and 19.8% by 2030 and 2050, respectively.
Pristine Surgical has finally been granted 510(k) clearance for its Summit 4K single-use surgical arthroscope from the US FDA. This latest version is estimated to improve the safety, consistency, and efficiency of arthroscopic procedures.
Olympus Corporation has announced its decisive decision to acquire Quest Photonic Devices B.V. This acquisition is projected to strengthen the company’s surgical endoscopy capabilities.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?